CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- 4 Open-market sale President, U.S. Market sold 8,500 shares at $84.09 ($714,745)
- 144 Insider Sale of Securities
- 13F-HR Other Quarterly Holdings of Institutional Investment Managers
- 144 Insider Sale of Securities
- 4 Open-market sale EVP,Chief Info&Digital Officer sold 6,000 shares at $85.34 ($512,057)
- 4 Option exercise President, U.S. Market acquired 13,002 shares (option exercise)
- 4 Open-market buy Director bought 2,832.86 shares at $88.25 ($250,000)
- 4 Open-market sale Chief Comm. & Public Afrs Ofcr sold 2,361 shares at $88.76 ($209,551)
- 4 Open-market buy Director bought 15,000 shares at $88.50 ($1,327,500)
- 144 Insider Sale of Securities
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award EVP, General Counsel acquired 25,423 shares (grant or award)
- 4 Grant or award EVP,Chief Info&Digital Officer acquired 10,246 shares (grant or award)
- 4 Grant or award SVP Fin. - Global Controller acquired 2,586 shares (grant or award)
Page 12 of 152 · 3,038 filings